Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05364073 |
|---|---|
| Brief Title: | Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations |
| First Submitted : | April 6, 2022 |
| First Submitted that Met QC Criteria : | May 3, 2022 |
| First Posted : | May 6, 2022 |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 19, 2024 |